<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Graf Acquisition Corp. IV 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=42862></link><description><![CDATA[Graf Acquisition Corp. IV 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 13 May 2026 21:47:33 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2023/03/12_31017998_20230327153728_8282242406.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination]]></title><link>https://www.newswire.co.kr/newsRead.php?no=963974</link><description><![CDATA[THE WOODLANDS, Texas & SANTA ANA, Calif.--(Business Wire/Korea Newswire)--Graf Acquisition Corp. IV (NYSE: GFOR) (“Graf”), a NYSE-listed special purpose acquisition company founded by serial SPAC founder James Graf, and NKGen Biotech, Inc. (“NKGen Biotech”), a biotechnology company focused on harnessing the power of the body’s immune system through the development of natural killer cell therapies, announced today that...]]></description><pubDate>Tue, 28 Mar 2023 10:30:00 +0900</pubDate></item><item><title><![CDATA[그라프 애퀴지션 IV와 NK젠 바이오테크, 기업결합 의향서 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=963975</link><description><![CDATA[우드랜즈, 텍사스/산타아나, 캘리포니아--(Business Wire/뉴스와이어)--시리얼 SPAC 설립자 제임스 그라프(James Graf)가 설립한 특수 인수 전문 회사 그라프 애퀴지션 IV(Graf Acquisition Corp. IV)(뉴욕증권거래소: GFOR)(이하 “그라프”)과 자연살해세포 요법 개발을 통해 신체 면역 체계의 힘을 활용하는 데 주력하는 생명공학 기업인 NK젠 바이오테크(NKGen Biotech, Inc.)는 오늘 구속력 없는 기업결합 의향서(“LOI”)에 서명했다고 발표했...]]></description><pubDate>Tue, 28 Mar 2023 10:30:00 +0900</pubDate></item></channel></rss>